pharm exam 2

The flashcards below were created by user jakeg on FreezingBlue Flashcards.

  1. A1 Agonist
  2. B1
  3. B2
  4. Hemostasis
    the physiologic process (coagulation cascade) by which bleeding is stopped
  5. Thrombosis
    the physiologic process by which a thrombus is formed.  Indicates abnormal hemostasis
  6. Thrombus
    • clot in a blood vessel or the heart
    • *Embolism= more dangerous
  7. Anticoagulants
    • Parenteral
    • -Heparin and heparin-related drugs
    • -Direct Thrombin Inhibitors
    • Oral
    • -Warfarin (Coumadin®)
  8. Heparin mech of action, admin, important issues
    • Mechanism of action: inactivates thrombin and other clotting factors indirectly by increasing activity of antithrombin à decreases clot formation especially in veins
    • Administration: parenteral (IV, SC) only.  Too large to cross membranes
    • Some important uses:Prevent postoperative venous thrombosis, Treat various embolic diseases (PE, stroke, DVT), Decrease clotting in heart-lung machines and dialysis units
    • -line patency
    • -during pregnancy (instead of Coumadin)
  9. Heparin part 2 sources, adrs, contradictions
    • Sources: beef lung and pig intestine
    • Important ADR’s:
    • Hemorrhage (the most common complication)  (platelet ct 150-400k)
    • Thrombocytopenia
    • Hypersensitivity reactions (from animal source)
    • Contraindications:
    • Active bleeding (<BP, >HR, <RBC, <HgB, ss of anemia, cold, SOB)
    • Thrombocytopenia
    • Certain surgeries/procedures (brain, spinal cord, eye)
    • Important drug interactions: drugs that also increase risk of bleeding (NSAIDs)
  10. Protamine sulfate
    Heparin overdose (binds to heparin to neutralize)
  11. aPTT
    • Monitor for Heparin
    • -Normal aPTT: 40 sec.
    • -Goal for anticoagulation: 1.5-2 x normal (60-80 sec.) (takes longer to clot)
    • -If aPTT too high, decrease dose
    • -If aPTT too low, increase dose
    • -Remember, to treat clots, the aPTT must be higher than normal without causing bleeding -Monitor aPTT q4-6 hrs. initially (then 1x/d)
  12. HIT
    • heparin induced thrombocytopenia
    • IGG mediated immune response to heparin
    • platelet count drops by 50+%
    • NEVER give heparin again
  13. Low Molecular Weight Heparin
    • enoxaparin (Lovenox)
    • -heparin preparations that are composed of smaller molecules than standard preparations. 
    • Differences from standard heparin:
    • -Does not inactivate thrombin like heparin, but does inactivate other clotting factors
    • -Is usually given SC only; rarely given IV
    • -Can be administered at home because…
    • -can be given on a fixed-dose schedule
    • -no need to monitor aPTT
    • -Less likely to cause thrombocytopenia
    • -Cheaper!  Because given at home
    • -if creatine clearance <30 only admin 1x/d(<dose)
  14. Factor XA Inhibitor
    • Example of heparin-like drug:
    • **Fondaparinux (Arixtra®)
    • -Smaller than LMWH
    • -Use to prevent and treat DVT/PE
    • ADR: Bleeding
    • -Do not use in patients with creatinine clearance below 30ml/min or weigh less than 50 kg
    • HIT not an issue
  15. Direct Thrombin Inhibitors
  16. oMechanism: inhibit thrombin directly whereas the heparin and heparin-like drugs inhibit indirectly
    • oExamples:
    • Bivalirudin (Angiomax®)- IV only; used with ASA to prevent clots in patients with USA undergoing coronary angioplasty
    • Lepirudin (Refludan®)- IV only; used for prophylaxis and treatment for thrombosis in patients with HIT
  17. Warfarin (Coumadin®) mech of action, admin, main use, ADR, contradiction
    • Mechanism of action: blocks the synthesis of 4 clotting factors (VII, IX, X, and prothrombin; which are vitamin K-dependent) à decreases clotting
    • Administration: oral
    • Main use is long-term prophylaxis for:
    • -venous thrombosis and DVT
    • -prosthetic heart valves
    • -atrial fibrillation
    • ADR: hemorrhage
    • Contraindications: pregnancy
  18. Wafarin Tx, drug interaction
    • Treatment in overdose: Vitamin K which is phytonadione (Mephyton/Aquamephyton)
    • Drug interactions: MANY!  Probably has the most drug interactions of any drug!
    • -Drugs that also cause increased bleeding/ or decreased clotting (Heparin, ASA)
    • (heparin used in conjunction until INR=2-3)
    • -Drugs that increase effects of warfarin (sulfonamide antibiotics)
    • -Drugs that decrease effects of warfarin- Example: anti-seizure drugs; rifampin, phenytoin, phenobarbitol, carbamazapine, dilantin
    • -Food-Green leafy veg
  19. INR
    • Monitoring for Warfarin
    • Lab test: INR (international normalized ratio)
    • INR is based on the prothrombin time (PT) and a correction factor.
    • -Normal prothrombin time (PT): 12 sec
    • -Anticoagulation goal (INR) for most patients: 2-3
    • *If INR too high, decrease dose
    • *If INR too low, increase dose
    • -Monitoring must be very frequent initially (daily) à monthly.
  20. Differences Between Heparin and Warfarin:
    • -Heparin must be given parenterally, warfarin is oral.
    • -Different mechanisms of action
    • -Heparin acts quickly, effects are brief. Warfarin acts more slowly, effects are prolonged. (3 d before full effects)
    • -Monitored differently (aPTT vs. INR)
    • -Antidotes for overdose are different
  21. Antiplatelet Drugs Three Main Groups
    • Aspirin (will cover more with pain module)
    • Adenosine Diphosphate Receptor Antagonists
    • *Clopidogrel (Plavix®)
    • *Ticlopidine (Ticlid®)*
    • Glycoprotein IIb/IIIa Receptor Antagonists
    • *Abciximab (ReoPro®)
    • *Eptifibatide (Integrilin®)*
    • *Tirofiban (Aggrastat®)*
  22. Aspirin (Bayer/Ecotrin)
    • Anti-platelets
    • -Inhibits platelet aggregation irreversibly
    • **Duration for the life of the platelets (7d)
    • -Used for prevention and treatment of MI, strokes, USA and occlusion of stents
    • ADR: bleeding, dyspepsia
  23. Clopidogrel (Plavix®)
    • Mechanism of action: causes irreversible blockade of ADP receptors on platelets à prevents ADP-stimulated platelet aggregation
    • Use: reduce risk of MI, stroke, cardiovascular death in those with CHD
    • Effectiveness: slightly better than aspirin
    • Cost: MUCH more than aspirin
    • ADR’s: generally well-tolerated, similar to aspirin such as dyspepsia
    • -May also cause TTP
    • Administration: PO
  24. Abciximab (ReoPro®)
    • Mechanism of action: causes reversible blockade of GP IIb/IIIa receptors on platelets à inhibits final step of platelet aggregation à decreases clotting
    • Effectiveness: member of most effective antiplatelet class available; AKA “super aspirins”.
    • Short-term uses:
    • -Acute coronary syndrome (unstable angina and evolving MI)
    • -Reduce reocclusion after angioplasty
    • **drug of choice for st segment elevation
    • Administration: IV
    • ADR’s: hemorrhage
  25. Thrombolytic Drugs Mech of action, Main use, Admin
    • "Clot Buster" breaks down new & existing clots (dangerous)
    • Mechanism of action: causes formation of plasmin, an enzyme that digests fibrin in clots that have already formed
    • Main uses:
    • -Acute MI
    • **best if begun ASAP within 4-6 hrs of symptom onset
    • -DVT
    • -Massive PE
    • Administration: IV
  26. Thrombolytics ADR, Absolute contradictions, Therapeutic uses w/ extreme caution, drug example
    • Main ADR:
    • -Hemorrhage
    • Absolute contraindications:
    • -Active bleeding
    • -Brain tumors
    • -Intracranial bleeding
    • -Suspected aortic dissection
    • Therapeutic uses with extreme caution:
    • -Ischemic stroke- must rule out intracranial hemorrhage with CT.  (“tPA” has been approved for this use)
    • ***Alteplase (Activase®)- “tPA”
Card Set:
pharm exam 2
2012-10-20 03:01:01

flash from cardio 2 pp
Show Answers: